Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Advanced Course on Cancer Vaccines and Cellular Immunotherapy 2022

Start date
29 Apr 2022
End date
30 Apr 2022
Virtual, CEST Time

Learning objectives

  • To acquire insights in the preclinical and clinical development of vaccines and cellular immunotherapeutic approaches against cancer
  • To learn about advances and ongoing research in optimal combinations of immunotherapeutic approaches involving vaccines and cell effectors, along with prognostic and predictive biomarkers
  • To obtain in-depth understanding of perspectives, bottlenecks and unmet needs in the evolving field of cancer vaccines and cellular immunotherapies

Download the programme


The programme of this virtual event has been accredited with 7 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.


  • Andrew Furness, United Kingdom
  • Pedro Romero, Switzerland

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.